References
- Nanchen D, Gencer B, Muller O, et al. Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes. Circulation. 2016;134(10):698–709. doi: 10.1161/CIRCULATIONAHA.116.023007
- Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1(6):445–664. doi: 10.1002/humu.1380010602
- Sturm AC, Knowles JW, Gidding SS, et al. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018;72(6):662–680. doi: 10.1016/j.jacc.2018.05.044
- Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34(45):3478–3490. doi: 10.1093/eurheartj/eht273
- McGowan MP, Hosseini Dehkordi SH, Moriarty PM, et al. Diagnosis and treatment of heterozygous familial hypercholesterolemia. J Am Heart Assoc. 2019;8(24):e013225. doi: 10.1161/JAHA.119.013225
- Wiesbauer F, Blessberger H, Azar D, et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age). Eur Heart J. 2009;30(9):1073–1079. doi: 10.1093/eurheartj/ehp051
- Wang X, Cai G, Wang Y, et al. Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia. Lipids Health Dis. 2019;18(1):131. doi: 10.1186/s12944-019-1074-8
- Zafrir B, Jubran A, Lavie G, et al. Clinical features and gaps in the management of probable familial hypercholesterolemia and cardiovascular disease. Circ J. 2017;82(1):218–223. doi: 10.1253/circj.CJ-17-0392
- Tada H, Kawashiri MA, Okada H, et al. Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography. Am J Cardiol. 2015;115(6):724–739. doi: 10.1016/j.amjcard.2014.12.034
- Danchin N, Farnier M, Zeller M, et al. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: the French registry of acute ST-elevation and non-ST-elevation myocardial infarction program. J Clin Lipidol. 2020;14(3):352–360.e6. doi: 10.1016/j.jacl.2020.03.008
- Al-Rasadi K, Al-Zakwani I, Alsheikh-Ali AA, et al. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf. J Clin Lipidol. 2018;12(3):685–692.e2. doi: 10.1016/j.jacl.2018.02.003
- Elbadawi A, Elgendy IY, Omer M, et al. Outcomes of acute myocardial infarction in patients with familial hypercholesteremia. Am J Med. 2021;134(8):992–1001.e4. doi: 10.1016/j.amjmed.2021.03.013
- Abe T, Olanipekun T, Adedinsewo D, et al. Trends and outcomes of ST‐Segment–Elevation myocardial infarction among young women in the United States. J Am Heart Assoc. 2023;12(5). doi: 10.1161/JAHA.122.026811
- Juhan N, Zubairi YZ, Zuhdi A, et al. Gender differences in mortality among ST elevation myocardial infarction patients in Malaysia from 2006 to 2013. Ann Saudi Med. 2018;38:1–7. doi:10.5144/0256-4947.2018.1
- Lichtman JH, Leifheit EC, Safdar B, et al. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO study (variation in recovery: role of gender on outcomes of young AMI patients). Circulation. 2018;137:781–790. doi: 10.1161/CIRCULATIONAHA.117.031650
- Marrugat J, Sala J, Masiá R, et al. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempo de Espera. JAMA. 1998 Oct 28; 280(16):1405–9. doi: 10.1001/jama.280.16.1405
- Sambola A, Del Blanco BG, Kunadian V, et al. Sex-based differences in percutaneous coronary intervention outcomes in patients with ischemic heart disease Eur Cardiol. 2023 Mar 2;18:e06. doi: 10.15420/ecr.2022.24
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2022 update: a report from the American heart association. Circulation. 2022;145(8). doi: 10.1161/CIR.0000000000001052
- Jneid H, Fonarow GC, Cannon CP, et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008;118(25)2803–2810. doi:10.1161/CIRCULATIONAHA.108.789800
- Cenko E, Yoon J, Kedev S, et al. Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med 2018;178(5)632. doi: 10.1001/jamainternmed.2018.0514
- Services DoHH. Healthcare cost & utilization project 5600 fishers Lane Rockville, MD 20857. U.S. Department of Health & Human Services; 2022. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
- Beheshti SO, Madsen CM, Varbo A, et al. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects. J Am Coll Cardiol. 2020;75(20):2553–2566. doi: 10.1016/j.jacc.2020.03.057
- Hu P, Dharmayat KI, Stevens CAT, et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Circulation. 2020;141(22):1742–5917. doi: 10.1161/CIRCULATIONAHA.119.044795
- de Ferranti SD, Rodday AM, Mendelson MM, et al. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation. 2016;133(11):1067–1072. doi: 10.1161/CIRCULATIONAHA.115.018791
- Kheiri B, Simpson TF, Osman M, et al. Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: incidence, predictors, and outcomes. J Clin Lipidol. 2021;15(3):460–546. doi: 10.1016/j.jacl.2021.04.005
- Belle L, Cayla G, Cottin Y, et al. French Registry on Acute ST-elevation and non-ST-elevation myocardial infarction 2015 (FAST-MI 2015). Design and baseline data. Arch Cardiovasc Dis. 2017;110(6–7):366–378. 10.1016/j.acvd.2017.05.001
- Mortensen MB, Kulenovic I, Klausen IC, et al. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: prevalence, risk factor burden, and impact on age at presentation. J Clin Lipidol. 2016;10(5):1145–1152.e1. doi: 10.1016/j.jacl.2016.06.002
- Rizos CV, Elisaf MS, Skoumas I, et al. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: data from the Hellenic familial hypercholesterolemia registry (HELLAS-FH). Atherosclerosis. 2018;277:308–313. doi: 10.1016/j.atherosclerosis.2018.08.017
- Agarwala A, Deych E, Jones LK, et al. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia. J Clin Lipidol. 2023;17(1):150–166. doi: 10.1016/j.jacl.2022.11.009
- Ryzhaya N, Cermakova L, Trinder M, et al. Sex differences in the presentation, treatment, and outcome of patients with familial hypercholesterolemia. J Am Heart Assoc. 2021;10(11):e019286. England. doi: 10.1161/JAHA.120.019286
- Iyen B, Qureshi N, Weng S, et al. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: a retrospective cohort study of the UK Simon Broome register linked to national hospital records. Atherosclerosis. 2020;315:131–713. doi: 10.1016/j.atherosclerosis.2020.10.895
- Cenko E, Yoon J, Kedev S, et al. Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med. 2018;178(5):632–964. doi: 10.1001/jamainternmed.2018.0514
- Ye G, Pattisapu VK, Wang P, et al. Sex differences and temporal trends in revascularization and outcomes of ST-Elevation myocardial infarction in older adults in the United States. Arch Med Res. 2022;53(4):441–450. doi: 10.1016/j.arcmed.2022.03.005
- Khera S, Kolte D, Gupta T, et al. Temporal trends and Sex differences in revascularization and outcomes of ST-Segment elevation myocardial infarction in younger adults in the United States. J Am Coll Cardiol. 2015;66(18):1961–7219. doi: 10.1016/j.jacc.2015.08.865
- Svendsen K, Krogh HW, Igland J, et al. 2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia. Atherosclerosis. 2021;319:28–34. doi: 10.1016/j.atherosclerosis.2020.12.019
- Zamora A, Ramos R, Comas-Cufi M, et al. Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men. Sci Rep. 2023;13(1):1492. doi: 10.1038/s41598-023-27963-z
- Balla S, Ekpo EP, Wilemon KA, et al. Women living with familial hypercholesterolemia: challenges and considerations surrounding their care. Curr Atheroscler Rep. 2020;22(10):60. doi: 10.1007/s11883-020-00881-5
- Whalen E. 2004. HCUP Nationwide Inpatient Sample (NIS) Comparison Report. HCUP Method Series Report # 2007-03.